{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T01:43:49Z","timestamp":1781660629557,"version":"3.54.5"},"reference-count":78,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T00:00:00Z","timestamp":1642464000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["R01-HL136685"],"award-info":[{"award-number":["R01-HL136685"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1007\/s00125-021-05641-x","type":"journal-article","created":{"date-parts":[[2022,1,18]],"date-time":"2022-01-18T09:17:11Z","timestamp":1642497431000},"page":"657-674","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Circulating metabolite profile in young adulthood identifies long-term diabetes susceptibility: the Coronary Artery Risk Development in Young Adults (CARDIA) study"],"prefix":"10.1007","volume":"65","author":[{"given":"Venkatesh L.","family":"Murthy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Nayor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Carnethon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared P.","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Lloyd-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norrina B.","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kitchen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Piaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyn M.","family":"Steffen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramachandran S.","family":"Vasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane E.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clary B.","family":"Clish","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4471-7156","authenticated-orcid":false,"given":"Ravi V.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,18]]},"reference":[{"issue":"4","key":"5641_CR1","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1038\/nm.2307","volume":"17","author":"TJ Wang","year":"2011","unstructured":"Wang TJ, Larson MG, Vasan RS et al (2011) Metabolite profiles and the risk of developing diabetes. Nat Med 17(4):448\u2013453. https:\/\/doi.org\/10.1038\/nm.2307","journal-title":"Nat Med"},{"issue":"9","key":"5641_CR2","doi-asserted-by":"publisher","first-page":"2508","DOI":"10.2337\/dc14-0560","volume":"37","author":"GA Walford","year":"2014","unstructured":"Walford GA, Porneala BC, Dauriz M et al (2014) Metabolite traits and genetic risk provide complementary information for the prediction of future type 2 diabetes. Diabetes Care 37(9):2508\u20132514. https:\/\/doi.org\/10.2337\/dc14-0560","journal-title":"Diabetes Care"},{"issue":"12","key":"5641_CR3","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1016\/j.jcmg.2014.07.017","volume":"7","author":"RV Shah","year":"2014","unstructured":"Shah RV, Murthy VL, Abbasi SA et al (2014) Visceral adiposity and the risk of metabolic syndrome across body mass index: the MESA study. JACC Cardiovasc Imaging 7(12):1221\u20131235. https:\/\/doi.org\/10.1016\/j.jcmg.2014.07.017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"10","key":"5641_CR4","doi-asserted-by":"publisher","first-page":"e003934","DOI":"10.1161\/JAHA.116.003934","volume":"5","author":"VL Murthy","year":"2016","unstructured":"Murthy VL, Abbasi SA, Siddique J et al (2016) Transitions in metabolic risk and long-term cardiovascular health: coronary artery risk development in young adults (CARDIA) study. J Am Heart Assoc 5(10):e003934. https:\/\/doi.org\/10.1161\/JAHA.116.003934","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"5641_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1016\/j.atherosclerosis.2014.05.962","volume":"235","author":"LB VanWagner","year":"2014","unstructured":"VanWagner LB, Ning H, Lewis CE et al (2014) Associations between nonalcoholic fatty liver disease and subclinical atherosclerosis in middle-aged adults: the coronary artery risk development in young adults study. Atherosclerosis 235(2):599\u2013605. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2014.05.962","journal-title":"Atherosclerosis"},{"issue":"12","key":"5641_CR6","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1161\/ATVBAHA.117.309633","volume":"37","author":"JG Terry","year":"2017","unstructured":"Terry JG, Shay CM, Schreiner PJ et al (2017) Intermuscular adipose tissue and subclinical coronary artery calcification in midlife: the CARDIA study (coronary artery risk development in young adults). Arterioscler Thromb Vasc Biol 37(12):2370\u20132378. https:\/\/doi.org\/10.1161\/ATVBAHA.117.309633","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"5641_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/ajcn\/69.3.381","volume":"69","author":"JO Hill","year":"1999","unstructured":"Hill JO, Sidney S, Lewis CE, Tolan K, Scherzinger AL, Stamm ER (1999) Racial differences in amounts of visceral adipose tissue in young adults: the CARDIA (coronary artery risk development in young adults) study. Am J Clin Nutr 69(3):381\u2013387. https:\/\/doi.org\/10.1093\/ajcn\/69.3.381","journal-title":"Am J Clin Nutr"},{"issue":"22","key":"5641_CR8","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1161\/CIRCULATIONAHA.120.047689","volume":"142","author":"VL Murthy","year":"2020","unstructured":"Murthy VL, Reis JP, Pico AR et al (2020) Comprehensive metabolic phenotyping refines cardiovascular risk in young adults. Circulation. 142(22):2110\u20132127. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.047689","journal-title":"Circulation."},{"issue":"20","key":"5641_CR9","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.120.050281","volume":"142","author":"M Nayor","year":"2020","unstructured":"Nayor M, Shah RV, Miller PE et al (2020) Metabolic architecture of acute exercise response in middle-aged adults in the community. Circulation. 142(20):1905\u20131924. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.120.050281","journal-title":"Circulation."},{"issue":"1","key":"5641_CR10","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1370\/afm.214","volume":"3","author":"RJ Koopman","year":"2005","unstructured":"Koopman RJ, Mainous AG 3rd, Diaz VA, Geesey ME (2005) Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000. Ann Fam Med 3(1):60\u201363. https:\/\/doi.org\/10.1370\/afm.214","journal-title":"Ann Fam Med"},{"issue":"4","key":"5641_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","volume":"9","author":"CB Newgard","year":"2009","unstructured":"Newgard CB, An J, Bain JR et al (2009) A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance. Cell Metab 9(4):311\u2013326. https:\/\/doi.org\/10.1016\/j.cmet.2009.02.002","journal-title":"Cell Metab"},{"issue":"12","key":"5641_CR12","doi-asserted-by":"publisher","first-page":"4394","DOI":"10.1172\/JCI95995","volume":"127","author":"JF O'Sullivan","year":"2017","unstructured":"O'Sullivan JF, Morningstar JE, Yang Q et al (2017) Dimethylguanidino valeric acid is a marker of liver fat and predicts diabetes. J Clin Invest 127(12):4394\u20134402. https:\/\/doi.org\/10.1172\/JCI95995","journal-title":"J Clin Invest"},{"issue":"19","key":"5641_CR13","doi-asserted-by":"publisher","first-page":"e012846","DOI":"10.1161\/JAHA.119.012846","volume":"8","author":"F Ottosson","year":"2019","unstructured":"Ottosson F, Ericson U, Almgren P et al (2019) Dimethylguanidino Valerate: a lifestyle-related metabolite associated with future coronary artery disease and cardiovascular mortality. J Am Heart Assoc 8(19):e012846. https:\/\/doi.org\/10.1161\/JAHA.119.012846","journal-title":"J Am Heart Assoc"},{"issue":"7","key":"5641_CR14","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1001\/jamacardio.2019.1573","volume":"4","author":"JM Robbins","year":"2019","unstructured":"Robbins JM, Herzig M, Morningstar J et al (2019) Association of Dimethylguanidino Valeric Acid with Partial Resistance to metabolic health benefits of regular exercise. JAMA Cardiol 4(7):636\u2013643. https:\/\/doi.org\/10.1001\/jamacardio.2019.1573","journal-title":"JAMA Cardiol"},{"issue":"6","key":"5641_CR15","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.2337\/db18-1076","volume":"68","author":"J Vangipurapu","year":"2019","unstructured":"Vangipurapu J, Stancakova A, Smith U, Kuusisto J, Laakso M (2019) Nine amino acids are associated with decreased insulin secretion and elevated glucose levels in a 7.4-year follow-up study of 5,181 Finnish men. Diabetes 68(6):1353\u20131358. https:\/\/doi.org\/10.2337\/db18-1076","journal-title":"Diabetes"},{"issue":"1","key":"5641_CR16","doi-asserted-by":"publisher","first-page":"e000103","DOI":"10.1136\/openhrt-2014-000103","volume":"1","author":"MF McCarty","year":"2014","unstructured":"McCarty MF, DiNicolantonio JJ (2014) The cardiometabolic benefits of glycine: is glycine an 'antidote' to dietary fructose? Open Heart 1(1):e000103. https:\/\/doi.org\/10.1136\/openhrt-2014-000103","journal-title":"Open Heart"},{"issue":"2","key":"5641_CR17","doi-asserted-by":"publisher","first-page":"639","DOI":"10.2337\/db12-0495","volume":"62","author":"A Floegel","year":"2013","unstructured":"Floegel A, Stefan N, Yu Z et al (2013) Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach. Diabetes 62(2):639\u2013648. https:\/\/doi.org\/10.2337\/db12-0495","journal-title":"Diabetes"},{"key":"5641_CR18","doi-asserted-by":"publisher","first-page":"2101562","DOI":"10.1155\/2018\/2101562","volume":"2018","author":"M El-Hafidi","year":"2018","unstructured":"El-Hafidi M, Franco M, Ramirez AR et al (2018) Glycine increases insulin sensitivity and glutathione biosynthesis and protects against oxidative stress in a model of sucrose-induced insulin resistance. Oxidative Med Cell Longev 2018:2101562. https:\/\/doi.org\/10.1155\/2018\/2101562","journal-title":"Oxidative Med Cell Longev"},{"issue":"2","key":"5641_CR19","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1016\/j.cmet.2019.11.019","volume":"31","author":"P Petrus","year":"2019","unstructured":"Petrus P, Lecoutre S, Dollet L et al (2019) Glutamine links obesity to inflammation in human White adipose tissue. Cell Metab 31(2):375\u2013390","journal-title":"Cell Metab"},{"issue":"2","key":"5641_CR20","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/sj.bjp.0707383","volume":"152","author":"S Chlopicki","year":"2007","unstructured":"Chlopicki S, Swies J, Mogielnicki A et al (2007) 1-Methylnicotinamide (MNA), a primary metabolite of nicotinamide, exerts anti-thrombotic activity mediated by a cyclooxygenase-2\/prostacyclin pathway. Br J Pharmacol 152(2):230\u2013239. https:\/\/doi.org\/10.1038\/sj.bjp.0707383","journal-title":"Br J Pharmacol"},{"issue":"8","key":"5641_CR21","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.2337\/db17-1449","volume":"67","author":"RN Lemaitre","year":"2018","unstructured":"Lemaitre RN, Yu C, Hoofnagle A et al (2018) Circulating sphingolipids, insulin, HOMA-IR, and HOMA-B: the strong heart family study. Diabetes 67(8):1663\u20131672. https:\/\/doi.org\/10.2337\/db17-1449","journal-title":"Diabetes"},{"key":"5641_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.3389\/fendo.2019.00577","volume":"10","author":"E Sokolowska","year":"2019","unstructured":"Sokolowska E, Blachnio-Zabielska A (2019) The role of ceramides in insulin resistance. Front Endocrinol (Lausanne) 10:577. https:\/\/doi.org\/10.3389\/fendo.2019.00577","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"11","key":"5641_CR23","doi-asserted-by":"publisher","first-page":"3072","DOI":"10.1016\/j.celrep.2018.02.060","volume":"22","author":"S Fujisaka","year":"2018","unstructured":"Fujisaka S, Avila-Pacheco J, Soto M et al (2018) Diet, genetics, and the gut microbiome drive dynamic changes in plasma metabolites. Cell Rep 22(11):3072\u20133086. https:\/\/doi.org\/10.1016\/j.celrep.2018.02.060","journal-title":"Cell Rep"},{"issue":"2","key":"5641_CR24","doi-asserted-by":"publisher","first-page":"488","DOI":"10.1016\/j.cmet.2018.09.022","volume":"29","author":"ET Cirulli","year":"2019","unstructured":"Cirulli ET, Guo L, Leon Swisher C et al (2019) Profound perturbation of the metabolome in obesity is associated with health risk. Cell Metab 29(2):488\u2013500 e482. https:\/\/doi.org\/10.1016\/j.cmet.2018.09.022","journal-title":"Cell Metab"},{"issue":"1","key":"5641_CR25","doi-asserted-by":"publisher","first-page":"13670","DOI":"10.1038\/s41598-017-13722-4","volume":"7","author":"T Pallister","year":"2017","unstructured":"Pallister T, Jackson MA, Martin TC et al (2017) Hippurate as a metabolomic marker of gut microbiome diversity: modulation by diet and relationship to metabolic syndrome. Sci Rep 7(1):13670. https:\/\/doi.org\/10.1038\/s41598-017-13722-4","journal-title":"Sci Rep"},{"issue":"5\u20136","key":"5641_CR26","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1159\/000479088","volume":"100","author":"JY Zhou","year":"2017","unstructured":"Zhou JY, Du XH, Zhang Z, Qian GS (2017) Trigonelline inhibits inflammation and protects beta cells to prevent fetal growth restriction during pregnancy in a mouse model of diabetes. Pharmacology 100(5\u20136):209\u2013217. https:\/\/doi.org\/10.1159\/000479088","journal-title":"Pharmacology"},{"issue":"2","key":"5641_CR27","doi-asserted-by":"publisher","first-page":"1331","DOI":"10.3892\/etm.2019.7698","volume":"18","author":"Y Li","year":"2019","unstructured":"Li Y, Li Q, Wang C, Lou Z, Li Q (2019) Trigonelline reduced diabetic nephropathy and insulin resistance in type 2 diabetic rats through peroxisome proliferator-activated receptor-gamma. Exp Ther Med 18(2):1331\u20131337. https:\/\/doi.org\/10.3892\/etm.2019.7698","journal-title":"Exp Ther Med"},{"issue":"2","key":"5641_CR28","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3945\/ajcn.116.130872","volume":"104","author":"JM Del Bas","year":"2016","unstructured":"Del Bas JM, Caimari A, Rodriguez-Naranjo MI et al (2016) Impairment of lysophospholipid metabolism in obesity: altered plasma profile and desensitization to the modulatory properties of n-3 polyunsaturated fatty acids in a randomized controlled trial. Am J Clin Nutr 104(2):266\u2013279. https:\/\/doi.org\/10.3945\/ajcn.116.130872","journal-title":"Am J Clin Nutr"},{"issue":"6","key":"5641_CR29","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1039\/c3mb70529c","volume":"10","author":"M Wallace","year":"2014","unstructured":"Wallace M, Morris C, O'Grada CM et al (2014) Relationship between the lipidome, inflammatory markers and insulin resistance. Mol BioSyst 10(6):1586\u20131595. https:\/\/doi.org\/10.1039\/c3mb70529c","journal-title":"Mol BioSyst"},{"issue":"9","key":"5641_CR30","doi-asserted-by":"publisher","first-page":"3331","DOI":"10.1210\/jc.2018-00480","volume":"103","author":"RD Semba","year":"2018","unstructured":"Semba RD, Gonzalez-Freire M, Moaddel R et al (2018) Altered plasma amino acids and lipids associated with abnormal glucose metabolism and insulin resistance in older adults. J Clin Endocrinol Metab 103(9):3331\u20133339. https:\/\/doi.org\/10.1210\/jc.2018-00480","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"5641_CR31","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1194\/jlr.M014787","volume":"52","author":"MS Han","year":"2011","unstructured":"Han MS, Lim YM, Quan W et al (2011) Lysophosphatidylcholine as an effector of fatty acid-induced insulin resistance. J Lipid Res 52(6):1234\u20131246. https:\/\/doi.org\/10.1194\/jlr.M014787","journal-title":"J Lipid Res"},{"issue":"12","key":"5641_CR32","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1007\/s00125-019-05001-w","volume":"62","author":"AV Ahola-Olli","year":"2019","unstructured":"Ahola-Olli AV, Mustelin L, Kalimeri M et al (2019) Circulating metabolites and the risk of type 2 diabetes: a prospective study of 11,896 young adults from four Finnish cohorts. Diabetologia 62(12):2298\u20132309. https:\/\/doi.org\/10.1007\/s00125-019-05001-w","journal-title":"Diabetologia"},{"issue":"6","key":"5641_CR33","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1007\/s00125-018-4599-x","volume":"61","author":"J Merino","year":"2018","unstructured":"Merino J, Leong A, Liu CT et al (2018) Metabolomics insights into early type 2 diabetes pathogenesis and detection in individuals with normal fasting glucose. Diabetologia 61(6):1315\u20131324. https:\/\/doi.org\/10.1007\/s00125-018-4599-x","journal-title":"Diabetologia"},{"issue":"7","key":"5641_CR34","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.3390\/jcm9072257","volume":"9","author":"A Hameed","year":"2020","unstructured":"Hameed A, Mojsak P, Buczynska A, Suleria HAR, Kretowski A, Ciborowski M (2020) Altered metabolome of lipids and amino acids species: a source of early signature biomarkers of T2DM. J Clin Med 9(7):2257. https:\/\/doi.org\/10.3390\/jcm9072257","journal-title":"J Clin Med"},{"issue":"6","key":"5641_CR35","doi-asserted-by":"publisher","first-page":"2158","DOI":"10.2337\/db13-0949","volume":"63","author":"AS Dimas","year":"2014","unstructured":"Dimas AS, Lagou V, Barker A et al (2014) Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 63(6):2158\u20132171. https:\/\/doi.org\/10.2337\/db13-0949","journal-title":"Diabetes"},{"issue":"1","key":"5641_CR36","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.1038\/s41598-018-20549-0","volume":"8","author":"W Lee","year":"2018","unstructured":"Lee W, Lee HJ, Jang HB et al (2018) Asymmetric dimethylarginine (ADMA) is identified as a potential biomarker of insulin resistance in skeletal muscle. Sci Rep 8(1):2133. https:\/\/doi.org\/10.1038\/s41598-018-20549-0","journal-title":"Sci Rep"},{"issue":"4","key":"5641_CR37","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1161\/ATVBAHA.108.162073","volume":"28","author":"K Sydow","year":"2008","unstructured":"Sydow K, Mondon CE, Schrader J, Konishi H, Cooke JP (2008) Dimethylarginine dimethylaminohydrolase overexpression enhances insulin sensitivity. Arterioscler Thromb Vasc Biol 28(4):692\u2013697. https:\/\/doi.org\/10.1161\/ATVBAHA.108.162073","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"8","key":"5641_CR38","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1007\/s00125-011-2197-2","volume":"54","author":"N Ikeda","year":"2011","unstructured":"Ikeda N, Inoguchi T, Sonoda N et al (2011) Biliverdin protects against the deterioration of glucose tolerance in db\/db mice. Diabetologia 54(8):2183\u20132191. https:\/\/doi.org\/10.1007\/s00125-011-2197-2","journal-title":"Diabetologia"},{"issue":"5","key":"5641_CR39","doi-asserted-by":"publisher","first-page":"L952","DOI":"10.1152\/ajplung.1999.277.5.L952","volume":"277","author":"MD Wheeler","year":"1999","unstructured":"Wheeler MD, Thurman RG (1999) Production of superoxide and TNF-alpha from alveolar macrophages is blunted by glycine. Am J Phys 277(5):L952\u2013L959. https:\/\/doi.org\/10.1152\/ajplung.1999.277.5.L952","journal-title":"Am J Phys"},{"issue":"8","key":"5641_CR40","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1177\/1753425916664124","volume":"22","author":"S Chen","year":"2016","unstructured":"Chen S, Liu Y, Wang X et al (2016) Asparagine improves intestinal integrity, inhibits TLR4 and NOD signaling, and differently regulates p38 and ERK1\/2 signaling in weanling piglets after LPS challenge. Innate Immun 22(8):577\u2013587. https:\/\/doi.org\/10.1177\/1753425916664124","journal-title":"Innate Immun"},{"issue":"11","key":"5641_CR41","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.2337\/diabetes.50.11.2563","volume":"50","author":"T Teruel","year":"2001","unstructured":"Teruel T, Hernandez R, Lorenzo M (2001) Ceramide mediates insulin resistance by tumor necrosis factor-alpha in brown adipocytes by maintaining Akt in an inactive dephosphorylated state. Diabetes 50(11):2563\u20132571. https:\/\/doi.org\/10.2337\/diabetes.50.11.2563","journal-title":"Diabetes"},{"issue":"23","key":"5641_CR42","doi-asserted-by":"publisher","first-page":"5901","DOI":"10.3390\/ijms20235901","volume":"20","author":"E Torretta","year":"2019","unstructured":"Torretta E, Barbacini P, Al-Daghri NM, Gelfi C (2019) Sphingolipids in obesity and correlated co-morbidities: the contribution of gender, age and environment. Int J Mol Sci 20(23):5901. https:\/\/doi.org\/10.3390\/ijms20235901","journal-title":"Int J Mol Sci"},{"key":"5641_CR43","doi-asserted-by":"publisher","first-page":"38","DOI":"10.3389\/fimmu.2018.00038","volume":"9","author":"V Chiurchiu","year":"2018","unstructured":"Chiurchiu V, Leuti A, Maccarrone M (2018) Bioactive lipids and chronic inflammation: managing the fire within. Front Immunol 9:38. https:\/\/doi.org\/10.3389\/fimmu.2018.00038","journal-title":"Front Immunol"},{"issue":"10","key":"5641_CR44","doi-asserted-by":"publisher","first-page":"e111348","DOI":"10.1371\/journal.pone.0111348","volume":"9","author":"S Heimerl","year":"2014","unstructured":"Heimerl S, Fischer M, Baessler A et al (2014) Alterations of plasma lysophosphatidylcholine species in obesity and weight loss. PLoS One 9(10):e111348. https:\/\/doi.org\/10.1371\/journal.pone.0111348","journal-title":"PLoS One"},{"key":"5641_CR45","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.bbadis.2012.05.008","volume":"9","author":"NE Braverman","year":"2012","unstructured":"Braverman NE, Moser AB (2012) Functions of plasmalogen lipids in health and disease. Biochim Biophys Acta 1822 9:1442\u20131452. https:\/\/doi.org\/10.1016\/j.bbadis.2012.05.008","journal-title":"Biochim Biophys Acta 1822"},{"issue":"8","key":"5641_CR46","doi-asserted-by":"publisher","first-page":"841","DOI":"10.1161\/CIRCULATIONAHA.117.029468","volume":"137","author":"NP Paynter","year":"2018","unstructured":"Paynter NP, Balasubramanian R, Giulianini F et al (2018) Metabolic predictors of incident coronary heart disease in women. Circulation 137(8):841\u2013853. https:\/\/doi.org\/10.1161\/CIRCULATIONAHA.117.029468","journal-title":"Circulation"},{"issue":"2","key":"5641_CR47","doi-asserted-by":"publisher","first-page":"614","DOI":"10.2337\/db10-0008","volume":"60","author":"M Al-Shabrawey","year":"2011","unstructured":"Al-Shabrawey M, Mussell R, Kahook K et al (2011) Increased expression and activity of 12-lipoxygenase in oxygen-induced ischemic retinopathy and proliferative diabetic retinopathy: implications in retinal neovascularization. Diabetes 60(2):614\u2013624. https:\/\/doi.org\/10.2337\/db10-0008","journal-title":"Diabetes"},{"issue":"5","key":"5641_CR48","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.cmet.2018.03.020","volume":"27","author":"KI Stanford","year":"2018","unstructured":"Stanford KI, Lynes MD, Takahashi H et al (2018) 12,13-diHOME: An exercise-induced Lipokine that increases skeletal muscle fatty acid uptake. Cell Metab 27(5):1111\u20131120 e1113. https:\/\/doi.org\/10.1016\/j.cmet.2018.03.020","journal-title":"Cell Metab"},{"issue":"5","key":"5641_CR49","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1038\/nm.4297","volume":"23","author":"MD Lynes","year":"2017","unstructured":"Lynes MD, Leiria LO, Lundh M et al (2017) The cold-induced lipokine 12,13-diHOME promotes fatty acid transport into brown adipose tissue. Nat Med 23(5):631\u2013637. https:\/\/doi.org\/10.1038\/nm.4297","journal-title":"Nat Med"},{"issue":"10","key":"5641_CR50","doi-asserted-by":"publisher","first-page":"1040","DOI":"10.1016\/j.numecd.2019.06.005","volume":"29","author":"X Liu","year":"2019","unstructured":"Liu X, Zheng Y, Guasch-Ferre M et al (2019) High plasma glutamate and low glutamine-to-glutamate ratio are associated with type 2 diabetes: case-cohort study within the PREDIMED trial. Nutr Metab Cardiovasc Dis 29(10):1040\u20131049. https:\/\/doi.org\/10.1016\/j.numecd.2019.06.005","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"9","key":"5641_CR51","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.2337\/db18-0927","volume":"68","author":"M Zhou","year":"2019","unstructured":"Zhou M, Shao J, Wu CY et al (2019) Targeting BCAA catabolism to treat obesity-associated insulin resistance. Diabetes 68(9):1730\u20131746. https:\/\/doi.org\/10.2337\/db18-0927","journal-title":"Diabetes"},{"issue":"5","key":"5641_CR52","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00726-011-0883-5","volume":"42","author":"T Ito","year":"2012","unstructured":"Ito T, Schaffer SW, Azuma J (2012) The potential usefulness of taurine on diabetes mellitus and its complications. Amino Acids 42(5):1529\u20131539. https:\/\/doi.org\/10.1007\/s00726-011-0883-5","journal-title":"Amino Acids"},{"key":"5641_CR53","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/s13098-020-0518-7","volume":"12","author":"V Maleki","year":"2020","unstructured":"Maleki V, Mahdavi R, Hajizadeh-Sharafabad F, Alizadeh M (2020) The effects of taurine supplementation on oxidative stress indices and inflammation biomarkers in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial. Diabetol Metab Syndr 12:9. https:\/\/doi.org\/10.1186\/s13098-020-0518-7","journal-title":"Diabetol Metab Syndr"},{"key":"5641_CR54","doi-asserted-by":"publisher","first-page":"2108909","DOI":"10.1155\/2016\/2108909","volume":"2016","author":"C Hellmuth","year":"2016","unstructured":"Hellmuth C, Kirchberg FF, Lass N et al (2016) Tyrosine is associated with insulin resistance in longitudinal Metabolomic profiling of obese children. J Diabetes Res 2016:2108909. https:\/\/doi.org\/10.1155\/2016\/2108909","journal-title":"J Diabetes Res"},{"issue":"5","key":"5641_CR55","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1007\/s00125-013-2839-7","volume":"56","author":"RN Feng","year":"2013","unstructured":"Feng RN, Niu YC, Sun XW et al (2013) Histidine supplementation improves insulin resistance through suppressed inflammation in obese women with the metabolic syndrome: a randomised controlled trial. Diabetologia 56(5):985\u2013994. https:\/\/doi.org\/10.1007\/s00125-013-2839-7","journal-title":"Diabetologia"},{"issue":"1","key":"5641_CR56","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1017\/S0007114511005289","volume":"108","author":"YC Niu","year":"2012","unstructured":"Niu YC, Feng RN, Hou Y et al (2012) Histidine and arginine are associated with inflammation and oxidative stress in obese women. Br J Nutr 108(1):57\u201361. https:\/\/doi.org\/10.1017\/S0007114511005289","journal-title":"Br J Nutr"},{"issue":"8","key":"5641_CR57","doi-asserted-by":"publisher","first-page":"3060","DOI":"10.1210\/jc.2018-00546","volume":"103","author":"F Ottosson","year":"2018","unstructured":"Ottosson F, Smith E, Melander O, Fernandez C (2018) Altered asparagine and glutamate homeostasis precede coronary artery disease and type 2 diabetes. J Clin Endocrinol Metab 103(8):3060\u20133069. https:\/\/doi.org\/10.1210\/jc.2018-00546","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"5641_CR58","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s13104-019-4130-6","volume":"12","author":"Z Darabi","year":"2019","unstructured":"Darabi Z, Darand M, Yari Z et al (2019) Inflammatory markers response to citrulline supplementation in patients with non-alcoholic fatty liver disease: a randomized, double blind, placebo-controlled, clinical trial. BMC Res Notes 12(1):89. https:\/\/doi.org\/10.1186\/s13104-019-4130-6","journal-title":"BMC Res Notes"},{"issue":"7","key":"5641_CR59","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1038\/ijo.2017.70","volume":"41","author":"T Pallister","year":"2017","unstructured":"Pallister T, Jackson MA, Martin TC et al (2017) Untangling the relationship between diet and visceral fat mass through blood metabolomics and gut microbiome profiling. Int J Obes 41(7):1106\u20131113. https:\/\/doi.org\/10.1038\/ijo.2017.70","journal-title":"Int J Obes"},{"key":"5641_CR60","doi-asserted-by":"publisher","unstructured":"Varadaiah YGC, Sivanesan S, Nayak SB, Thirumalarao KR (2019) Purine metabolites can indicate diabetes progression. Arch Physiol Biochem 1\u20135. https:\/\/doi.org\/10.1080\/13813455.2019.1663219","DOI":"10.1080\/13813455.2019.1663219"},{"issue":"1","key":"5641_CR61","doi-asserted-by":"publisher","first-page":"3016","DOI":"10.1038\/s41598-018-21099-1","volume":"8","author":"K Strom","year":"2018","unstructured":"Strom K, Morales-Alamo D, Ottosson F et al (2018) N(1)-methylnicotinamide is a signalling molecule produced in skeletal muscle coordinating energy metabolism. Sci Rep 8(1):3016. https:\/\/doi.org\/10.1038\/s41598-018-21099-1","journal-title":"Sci Rep"},{"issue":"8","key":"5641_CR62","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/nm.3882","volume":"21","author":"S Hong","year":"2015","unstructured":"Hong S, Moreno-Navarrete JM, Wei X et al (2015) Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization. Nat Med 21(8):887\u2013894. https:\/\/doi.org\/10.1038\/nm.3882","journal-title":"Nat Med"},{"key":"5641_CR63","doi-asserted-by":"publisher","first-page":"1080152","DOI":"10.1155\/2020\/1080152","volume":"2020","author":"J Zhang","year":"2020","unstructured":"Zhang J, Chen Y, Liu C, Li L, Li P (2020) N(1)-Methylnicotinamide improves hepatic insulin sensitivity via activation of SIRT1 and inhibition of FOXO1 acetylation. J Diabetes Res 2020:1080152. https:\/\/doi.org\/10.1155\/2020\/1080152","journal-title":"J Diabetes Res"},{"issue":"1","key":"5641_CR64","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1186\/s12916-016-0693-4","volume":"14","author":"L Chaker","year":"2016","unstructured":"Chaker L, Ligthart S, Korevaar TI et al (2016) Thyroid function and risk of type 2 diabetes: a population-based prospective cohort study. BMC Med 14(1):150. https:\/\/doi.org\/10.1186\/s12916-016-0693-4","journal-title":"BMC Med"},{"issue":"2","key":"5641_CR65","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1111\/apha.12647","volume":"217","author":"AC Panveloski-Costa","year":"2016","unstructured":"Panveloski-Costa AC, Silva Teixeira S, Ribeiro IM et al (2016) Thyroid hormone reduces inflammatory cytokines improving glycaemia control in alloxan-induced diabetic wistar rats. Acta Physiol (Oxford) 217(2):130\u2013140. https:\/\/doi.org\/10.1111\/apha.12647","journal-title":"Acta Physiol (Oxford)"},{"issue":"3","key":"5641_CR66","doi-asserted-by":"publisher","first-page":"e13550","DOI":"10.14814\/phy2.13550","volume":"6","author":"AC Panveloski-Costa","year":"2018","unstructured":"Panveloski-Costa AC, Serrano-Nascimento C, Bargi-Souza P, Poyares LL, Viana GS, Nunes MT (2018) Beneficial effects of thyroid hormone on adipose inflammation and insulin sensitivity of obese Wistar rats. Physiol Rep 6(3):e13550. https:\/\/doi.org\/10.14814\/phy2.13550","journal-title":"Physiol Rep"},{"issue":"1","key":"5641_CR67","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/jcm8010071","volume":"8","author":"JC Fernandez-Garcia","year":"2019","unstructured":"Fernandez-Garcia JC, Delpino-Rius A, Samarra I et al (2019) Type 2 diabetes is associated with a different pattern of serum polyamines: a case(\u2212)control study from the PREDIMED-plus trial. J Clin Med 8(1):71. https:\/\/doi.org\/10.3390\/jcm8010071","journal-title":"J Clin Med"},{"issue":"1","key":"5641_CR68","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.bbrc.2018.09.078","volume":"505","author":"M Gao","year":"2018","unstructured":"Gao M, Zhao W, Li C et al (2018) Spermidine ameliorates non-alcoholic fatty liver disease through regulating lipid metabolism via AMPK. Biochem Biophys Res Commun 505(1):93\u201398. https:\/\/doi.org\/10.1016\/j.bbrc.2018.09.078","journal-title":"Biochem Biophys Res Commun"},{"issue":"6","key":"5641_CR69","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1111\/obr.12843","volume":"20","author":"R Zhuang","year":"2019","unstructured":"Zhuang R, Ge X, Han L et al (2019) Gut microbe-generated metabolite trimethylamine N-oxide and the risk of diabetes: a systematic review and dose-response meta-analysis. Obes Rev 20(6):883\u2013894. https:\/\/doi.org\/10.1111\/obr.12843","journal-title":"Obes Rev"},{"issue":"11","key":"5641_CR70","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1007\/s00125-019-4947-5","volume":"62","author":"SK Vasan","year":"2019","unstructured":"Vasan SK, Noordam R, Gowri MS, Neville MJ, Karpe F, Christodoulides C (2019) The proposed systemic thermogenic metabolites succinate and 12,13-diHOME are inversely associated with adiposity and related metabolic traits: evidence from a large human cross-sectional study. Diabetologia 62(11):2079\u20132087. https:\/\/doi.org\/10.1007\/s00125-019-4947-5","journal-title":"Diabetologia"},{"key":"5641_CR71","doi-asserted-by":"publisher","first-page":"117443","DOI":"10.1016\/j.lfs.2020.117443","volume":"247","author":"P Liu","year":"2020","unstructured":"Liu P, Zhu W, Chen C et al (2020) The mechanisms of lysophosphatidylcholine in the development of diseases. Life Sci 247:117443. https:\/\/doi.org\/10.1016\/j.lfs.2020.117443","journal-title":"Life Sci"},{"issue":"3","key":"5641_CR72","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s12576-012-0196-9","volume":"62","author":"D Zhu","year":"2012","unstructured":"Zhu D, Ran Y (2012) Role of 15-lipoxygenase\/15-hydroxyeicosatetraenoic acid in hypoxia-induced pulmonary hypertension. J Physiol Sci 62(3):163\u2013172. https:\/\/doi.org\/10.1007\/s12576-012-0196-9","journal-title":"J Physiol Sci"},{"issue":"6","key":"5641_CR73","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1002\/hep.23229","volume":"50","author":"P Puri","year":"2009","unstructured":"Puri P, Wiest MM, Cheung O et al (2009) The plasma lipidomic signature of nonalcoholic steatohepatitis. Hepatology 50(6):1827\u20131838. https:\/\/doi.org\/10.1002\/hep.23229","journal-title":"Hepatology"},{"issue":"6","key":"5641_CR74","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1172\/JCI117252","volume":"93","author":"G Boden","year":"1994","unstructured":"Boden G, Chen X, Ruiz J, White JV, Rossetti L (1994) Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93(6):2438\u20132446. https:\/\/doi.org\/10.1172\/JCI117252","journal-title":"J Clin Invest"},{"issue":"5","key":"5641_CR75","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1073\/pnas.95.5.2498","volume":"95","author":"M Shimabukuro","year":"1998","unstructured":"Shimabukuro M, Zhou YT, Levi M, Unger RH (1998) Fatty acid-induced beta cell apoptosis: a link between obesity and diabetes. Proc Natl Acad Sci U S A 95(5):2498\u20132502. https:\/\/doi.org\/10.1073\/pnas.95.5.2498","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"5641_CR76","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1007\/s11906-001-0021-y","volume":"3","author":"BM Egan","year":"2001","unstructured":"Egan BM, Greene EL, Goodfriend TL (2001) Nonesterified fatty acids in blood pressure control and cardiovascular complications. Curr Hypertens Rep 3(2):107\u2013116. https:\/\/doi.org\/10.1007\/s11906-001-0021-y","journal-title":"Curr Hypertens Rep"},{"issue":"10","key":"5641_CR77","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/S2213-8587(14)70146-9","volume":"2","author":"NG Forouhi","year":"2014","unstructured":"Forouhi NG, Koulman A, Sharp SJ et al (2014) Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study. Lancet Diabetes Endocrinol 2(10):810\u2013818. https:\/\/doi.org\/10.1016\/S2213-8587(14)70146-9","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"7","key":"5641_CR78","doi-asserted-by":"publisher","first-page":"718","DOI":"10.1096\/fj.01-0816fje","volume":"16","author":"M Heim","year":"2002","unstructured":"Heim M, Johnson J, Boess F et al (2002) Phytanic acid, a natural peroxisome proliferator-activated receptor (PPAR) agonist, regulates glucose metabolism in rat primary hepatocytes. FASEB J 16(7):718\u2013720. https:\/\/doi.org\/10.1096\/fj.01-0816fje","journal-title":"FASEB J"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05641-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00125-021-05641-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-021-05641-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,18]],"date-time":"2023-01-18T03:27:55Z","timestamp":1674012475000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00125-021-05641-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,18]]},"references-count":78,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["5641"],"URL":"https:\/\/doi.org\/10.1007\/s00125-021-05641-x","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,18]]},"assertion":[{"value":"22 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 January 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}